NEXALIN TECHNOLOGY INC C/WTS ( TO PUR COM ) Stock Forum

Nexalin Technology's Gen-2 Neurostimulation Device Receives Approval in Brazil.
On June 17, 2024, Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), a company known for its innovative neurostimulation products, announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency (ANVISA). ANVISA is a regulatory body under the Br...